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Background: The recent generation of induced pluripotent stem (iPS) cells allows generation of patient-specific pluripotent stem cells thereby 
opening a new gate for cell transplantation-based regenerative medicine. Despite the vast variety of methods introduced to generate iPS cells, 
there is a lack of careful characterization of these cells for clinical use. This study therefore is aimed at assessing 1) the cardiomyocyte (CM) 
differentiation properties of different types of iPS cell lines including their potentiality, time course, and efficiency of the cardiac differentiation in 
vitro, and 2) the properties of the iPS cell-derived CMs.
Methods: Several lines of mouse Fbx-iPS and Nanog-iPS cells were used, and CMs were induced using hanging drop culture method. Mouse ES 
cells were used as control. Detail characterization of several iPS cell lines was performed in terms of stem cell marker expression and transgene 
expression. CM differentiation potential was compared among iPS cell lines, and molecular and electrophysiological properties of iPS cell-derived 
CMs were analysed.
Results: High-quality iPS cells which highly expressed stem cell markers without transgene expression showed better CM differentiation properties 
in terms of time point and efficiency. Low-quality iPS cells which also expressed stem cell markers with residual transgene expression hardly ever 
differentiated into CMs. Purified low-quality iPS cell-derived CMs retain residual transgene expression which may have contributed to lower incidence 
of beating colonies. However, interestingly, despite its stem cell quality, the iPS cell-derived CM showed normal characteristics. Electrophysiological 
study demonstrated that iPS cell-derived CMs have sinus node-like and fetal ventricular type action potentials. Moreover, pharmacological studies 
demonstrated that iPS cell-derived CMs have normal chronotropic responses.
Conclusions: Because of the differences in properties shown in this study and the potential safety hazards of persistent transgene expression, 
characterization of newly established iPS cells is a prerequisite for use in cardiac regenerative medicine.
